Agency
Talbot Clinical Services of Ohio LLC
Talbot Clinical Services of Ohio LLC was paid $10.83M by Medicaid between Jan 2018 and Dec 2024, across 35 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoTALBOT CLINICAL SERVICES OF OHIO LLC
TOLEDO, OH 43605
TOLEDO, OH 43605
33aNPI1245635549assigned 10/29/2014
33bProvider typeCommunity/Behavioral Health Agency
28Total paid$10.83M
24GClaims215,604
24DCodes billed35
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Behavioral Health Agency providers in Ohio
Rank by total paid#52 of 417
Median peer was paid$469K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,907 | $673K | |
| 2019 | 21,229 | $1.03M | |
| 2020 | 18,272 | $945K | |
| 2021 | 17,618 | $925K | |
| 2022 | 31,963 | $1.94M | |
| 2023 | 51,770 | $3.00M | |
| 2024incomplete | 58,845 | $2.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 26,450 | 17,695 | $2.96M |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 16% | 18,455 | 11,889 | $1.73M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 8.7% | 9,893 | 5,385 | $940K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.4% | 17,962 | 12,356 | $800K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 4.9% | 11,439 | 7,788 | $526K |
| H0006 | Alcohol and/or drug services; case management | 4.6% | 20,637 | 14,597 | $495K |
| T1002 | Rn services, up to 15 minutes | 4.6% | 18,108 | 12,408 | $495K |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 4.3% | 33,339 | 23,298 | $469K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 4.0% | 3,141 | 2,279 | $433K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 4,353 | 3,176 | $343K |
| T1003 | Lpn/lvn services, up to 15 minutes | 2.9% | 13,776 | 10,247 | $313K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 2.6% | 2,089 | 625 | $281K |
23 more codes
| H2036 | Alcohol and/or other drug treatment program, per diem | 2.1% | 1,097 | $223K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | 1.8% | 11,439 | $191K |
| 90791 | Psychiatric diagnostic evaluation | 1.1% | 1,072 | $114K |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | <1% | 6,836 | $106K |
| J0575 | Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine | <1% | 6,514 | $86K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 489 | $75K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 401 | $63K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,162 | $55K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 765 | $54K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 846 | $16K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 221 | $16K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 302 | $16K |
| 99205 | Prolong outpt/office vis | <1% | 61 | $11K |
| 81025 | <1% | 1,697 | $7K | |
| 80305 | <1% | 2,523 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 82 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 82 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 82 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 82 | $2K |
| 99201 | <1% | 16 | $666.67 | |
| 82075 | <1% | 15 | $259.88 | |
| 90785 | <1% | 113 | $140.88 | |
| 86780 | <1% | 65 | $5.46 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUNBAR, OLIVIA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Talbot Clinical Services of Ohio LLC | Toledo, OH | $1.50M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.